January 12, 2022
Investigators from the New York Blood Center (NYBC), including National Blood Foundation Hall of Fame member and former Foundation Board trustee Christopher D. Hillyer, MD, recently published a study that reports the discovery of highly potent small molecules that may have the ability to inhibit COVID-19 in infected individuals. According to investigators, this discovery could potentially lead to a treatment for COVID-19, as well as other existing and future coronavirus diseases. The research team published their findings (open access) last month in the journal Viruses.
Hillyer, the President and CEO of NYBC and professor in the Department of Medicine at Weill Cornell Medical College, is a past AABB president, a prolific author of transfusion medicine publications, and the 2014 recipient of AABB’s Emily Cooley Award. He is also a 1991 recipient of a National Blood Foundation early-career Scientific Research Grant.
For many young investigators, an NBF grant is a career milestone that validates their research scope as their career trajectory is just taking shape. And like Hillyer, many of these NBF-supported investigators go on to drive innovation in the field for years to come.
A donation to the NBF is an investment in the next generation of young investigators. Make your gift today! Future medical breakthroughs improving patient and donor care depend on it.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
